First Time Loading...

LivaNova PLC
NASDAQ:LIVN

Watchlist Manager
LivaNova PLC Logo
LivaNova PLC
NASDAQ:LIVN
Watchlist
Price: 55.1 USD -1.5% Market Closed
Updated: Apr 26, 2024

Intrinsic Value

LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare system... [ Read More ]

The intrinsic value of one LIVN stock under the Base Case scenario is 73.69 USD. Compared to the current market price of 55.1 USD, LivaNova PLC is Undervalued by 25%.

Key Points:
LIVN Intrinsic Value
Base Case
73.69 USD
Undervaluation 25%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
LivaNova PLC

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling LIVN stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
LivaNova PLC

Provide an overview of the primary business activities
of LivaNova PLC.

What unique competitive advantages
does LivaNova PLC hold over its rivals?

What risks and challenges
does LivaNova PLC face in the near future?

Has there been any significant insider trading activity
in LivaNova PLC recently?

Summarize the latest earnings call
of LivaNova PLC.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for LivaNova PLC.

Provide P/S
for LivaNova PLC.

Provide P/E
for LivaNova PLC.

Provide P/OCF
for LivaNova PLC.

Provide P/FCFE
for LivaNova PLC.

Provide P/B
for LivaNova PLC.

Provide EV/S
for LivaNova PLC.

Provide EV/GP
for LivaNova PLC.

Provide EV/EBITDA
for LivaNova PLC.

Provide EV/EBIT
for LivaNova PLC.

Provide EV/OCF
for LivaNova PLC.

Provide EV/FCFF
for LivaNova PLC.

Provide EV/IC
for LivaNova PLC.

Show me price targets
for LivaNova PLC made by professional analysts.

What are the Revenue projections
for LivaNova PLC?

How accurate were the past Revenue estimates
for LivaNova PLC?

What are the Net Income projections
for LivaNova PLC?

How accurate were the past Net Income estimates
for LivaNova PLC?

What are the EPS projections
for LivaNova PLC?

How accurate were the past EPS estimates
for LivaNova PLC?

What are the EBIT projections
for LivaNova PLC?

How accurate were the past EBIT estimates
for LivaNova PLC?

Compare the revenue forecasts
for LivaNova PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of LivaNova PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of LivaNova PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of LivaNova PLC compared to its peers.

Compare the P/E ratios
of LivaNova PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing LivaNova PLC with its peers.

Analyze the financial leverage
of LivaNova PLC compared to its main competitors.

Show all profitability ratios
for LivaNova PLC.

Provide ROE
for LivaNova PLC.

Provide ROA
for LivaNova PLC.

Provide ROIC
for LivaNova PLC.

Provide ROCE
for LivaNova PLC.

Provide Gross Margin
for LivaNova PLC.

Provide Operating Margin
for LivaNova PLC.

Provide Net Margin
for LivaNova PLC.

Provide FCF Margin
for LivaNova PLC.

Show all solvency ratios
for LivaNova PLC.

Provide D/E Ratio
for LivaNova PLC.

Provide D/A Ratio
for LivaNova PLC.

Provide Interest Coverage Ratio
for LivaNova PLC.

Provide Altman Z-Score Ratio
for LivaNova PLC.

Provide Quick Ratio
for LivaNova PLC.

Provide Current Ratio
for LivaNova PLC.

Provide Cash Ratio
for LivaNova PLC.

What is the historical Revenue growth
over the last 5 years for LivaNova PLC?

What is the historical Net Income growth
over the last 5 years for LivaNova PLC?

What is the current Free Cash Flow
of LivaNova PLC?

Discuss the annual earnings per share (EPS)
trend over the past five years for LivaNova PLC.

Financials

Balance Sheet Decomposition
LivaNova PLC

Current Assets 988.2m
Cash & Short-Term Investments 266.5m
Receivables 215.1m
Other Current Assets 506.6m
Non-Current Assets 1.4B
Long-Term Investments 22.8m
PP&E 205m
Intangibles 1B
Other Non-Current Assets 169.4m
Current Liabilities 335m
Accounts Payable 80.8m
Accrued Liabilities 187.3m
Other Current Liabilities 66.8m
Non-Current Liabilities 817m
Long-Term Debt 568.5m
Other Non-Current Liabilities 248.4m
Efficiency

Earnings Waterfall
LivaNova PLC

Revenue
1.2B USD
Cost of Revenue
-382.3m USD
Gross Profit
771.3m USD
Operating Expenses
-714.3m USD
Operating Income
57m USD
Other Expenses
-39.4m USD
Net Income
17.5m USD

Free Cash Flow Analysis
LivaNova PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

LIVN Profitability Score
Profitability Due Diligence

LivaNova PLC's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROE is Increasing
ROIC is Increasing
Positive 3-Years Revenue Growth
45/100
Profitability
Score

LivaNova PLC's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

LIVN Solvency Score
Solvency Due Diligence

LivaNova PLC's solvency score is 46/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Positive Net Debt
46/100
Solvency
Score

LivaNova PLC's solvency score is 46/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LIVN Price Targets Summary
LivaNova PLC

Wall Street analysts forecast LIVN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LIVN is 69.36 USD with a low forecast of 55.55 USD and a high forecast of 86.1 USD.

Lowest
Price Target
55.55 USD
1% Upside
Average
Price Target
69.36 USD
26% Upside
Highest
Price Target
86.1 USD
56% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

LIVN Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

LIVN Price
LivaNova PLC

1M 1M
+1%
6M 6M
+17%
1Y 1Y
+14%
3Y 3Y
-33%
5Y 5Y
-22%
10Y 10Y
-21%
Annual Price Range
55.1
52w Low
43.45
52w High
58.87
Price Metrics
Average Annual Return -2.34%
Standard Deviation of Annual Returns 30.04%
Max Drawdown -60%
Shares Statistics
Market Capitalization 3B USD
Shares Outstanding 53 956 200
Percentage of Shares Shorted 7.04%

LIVN Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

LivaNova PLC Logo
LivaNova PLC

Country

United Kingdom

Industry

Health Care

Market Cap

3B USD

Dividend Yield

0%

Description

LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. The firm is focused on the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals and healthcare systems throughout the world. The firm operates through two segments: Cardiac Surgery and Neuromodulation. Its Cardiac Surgery Business Franchise (CS) is engaged in the development, production and sale of cardiac surgery products, including oxygenators, heart-lung machines, perfusion tubing systems, cannulae and other accessories used for extracorporeal circulation, systems for autologous blood transfusion and blood washing. Its Neuromodulation Business Franchise designs develops and markets neuromodulation-based medical devices for the treatment of epilepsy and difficult-to-treat depression (DTD) and obstructive sleep apnea.

Contact

London
20 Eastbourne Terrace
+442033250662.0
http://www.livanova.com/home.action

IPO

2015-10-19

Employees

3 000

Officers

Chief Financial Officer
Mr. Alex Shvartsburg
Chief Human Resources Officer
Ms. Trui Hebbelinck
CEO & Director
Mr. Vladimir A. Makatsaria
Chief Technology Officer
Mr. Badri Amurthur
Senior Director of Investor Relations
Lindsey Little
Senior VP, Chief Legal Officer & Company Secretary
Mr. Michael D. Hutchinson
Show More
Vice President of Corporate Communications
Deanna Wilke
Senior Vice President of Corporate Development & IT
Mr. Matthew Joseph Dodds III
Senior VP & Head of Product Development - Neuromodulation
Dr. Bryan D. Olin Ph.D.
President of Advanced Circulatory Support
Mr. Ryan Miller
Show Less

See Also

Discover More
What is the Intrinsic Value of one LIVN stock?

The intrinsic value of one LIVN stock under the Base Case scenario is 73.69 USD.

Is LIVN stock undervalued or overvalued?

Compared to the current market price of 55.1 USD, LivaNova PLC is Undervalued by 25%.